Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.25862
Abstract: Efavirenz (EFV) is commonly used for first‐line antiretroviral therapy in children and adolescents with HIV, but is associated with neuropsychiatric and metabolic side effects. Rilpivirine (RPV) is better tolerated, and switching from EFV to RPV… read more here.
Keywords: virologically suppressed; suppressed adolescents; switching efavirenz; week ... See more keywords
Excessive weight gain: current antiretroviral agents in virologically suppressed people with HIV.
Sign Up to like & getrecommendations! Published in 2022 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2021.0188
Abstract: An observational cohort study was conducted with data from the Observational Pharmaco-Epidemiology Research & Analysis (OPERA) cohort to investigate weight gain among virologically suppressed people with HIV (PWH) switching to regimens containing tenofovir alafenamide/emtricitabine/ (TAF/FTC).… read more here.
Keywords: virologically suppressed; gain; within weeks; weight gain ... See more keywords
Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients.
Sign Up to like & getrecommendations! Published in 2023 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2022.0130
Abstract: Recent studies suggest that the introduction of antiretroviral agents such as integrase strand transfer inhibitors (INSTI) may lead to more weight gain in patients living with HIV (PLHIV). In this retrospective observational study, we report… read more here.
Keywords: months switching; suppressed hiv; virologically suppressed; weight gain ... See more keywords
Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional study
Sign Up to like & getrecommendations! Published in 2022 at "PLOS ONE"
DOI: 10.1371/journal.pone.0277231
Abstract: There are limited data regarding bone health in older people living with HIV (PWH), especially those of Asian ethnicity. We aimed to determine whether BMD in well-suppressed HIV-infected men and women aged ≥ 50 years… read more here.
Keywords: virologically suppressed; hiv; pwh; sectional study ... See more keywords
Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.977316
Abstract: Background Iron metabolism plays an essential role in cellular functions. Since virologically suppressed chronic HIV-infected subjects under effective antiretroviral treatment (ART) exhibit a persistent immune dysfunction that leads to comorbidities, iron homeostasis may be relevant… read more here.
Keywords: virologically suppressed; hiv; iron; hiv infected ... See more keywords
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
Sign Up to like & getrecommendations! Published in 2023 at "Viruses"
DOI: 10.3390/v15040936
Abstract: Background: The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir (DTG) plus lamivudine (3TC) have led to international guidelines recommending their use for treatment-naive HIV patients. In virologically suppressed patients, de-escalating from… read more here.
Keywords: virologically suppressed; safety; hiv; dtg plus ... See more keywords